Cytokinetics, Incorporated · NASDAQ:CYTK
Lee Sung sold 38,730 Cytokinetics, Incorporated shares (Form 4)
Traded Jun 24, 2026 · Filed Jun 29, 2026
On Jun 24, 2026, Lee Sung (EVP, Chief Financial Officer) sold 38,730 Cytokinetics, Incorporated shares at US$82.30 for US$3.19M under a trading plan, leaving 63,221 shares. Filed Jun 29, 2026 (Form 4).
- Sold
- 38,730 shares
- Price
- US$82.30
- Value
- US$3.19M
- Holding after
- 63,221 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 24, 2026 | Common Stock | Option exercise | 23,370 | US$48.51 | 86,591 | Direct |
| Jun 24, 2026 | Common Stock | Option exercise | 9,307 | US$44.36 | 95,898 | Direct |
| Jun 24, 2026 | Common Stock | Option exercise | 2,817 | US$44.36 | 98,715 | Direct |
| Jun 24, 2026 | Common Stock | Option exercise | 1,113 | US$48.51 | 99,828 | Direct |
| Jun 24, 2026 | Common Stock | Option exercise | 188 | US$44.36 | 100,016 | Direct |
| Jun 24, 2026 | Common Stock | Option exercise | 822 | US$44.36 | 100,838 | Direct |
| Jun 24, 2026 | Common Stock | Sale | 38,730 | US$82.30 | 63,221 | Direct |
Source
Related
- Cytokinetics, Incorporated
- Lee Sung
- Cytokinetics, Incorporated shareholders
- Form 4 · Lee Sung · Jul 2, 2026
- Form 4 · Lee Sung · Jun 29, 2026
- Form 4 · Lee Sung · May 5, 2026
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026